Advertisement

Thyroid Carcinoma

  • C. B. Caldwell
  • C. D. ShermanJr.
Part of the UICC International Union Against Cancer book series (UICCI)

Abstract

Most patients with thyroid cancers typically have a chronic disease. Many live 15–20 years with obvious metastases but without major progression of the disease or physical or functional deterioration. This chronicity and the disease’s low incidence make it difficult to evaluate different treatment methods.

Keywords

Thyroid Cancer Thyroid Carcinoma Papillary Thyroid Carcinoma Thyroid Nodule Total Thyroidectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  1. Beierwaltes WH, Rabbani R, Dmujchowski C, Lloyd RV, Eyre P, Mallette S (1984) An analysis of “Ablation of Thyroid Remnants” with I131 in 511 patients from 1947–1984: experience at University of Michigan. Journal of Nuclear Medicine 25: 1287–1293PubMedGoogle Scholar
  2. Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947–953PubMedGoogle Scholar
  3. Cady B, Rossi R (eds) (1991) Surgery of the thyroid and parathyroid glands. Saunders, PhiladelphiaGoogle Scholar
  4. Caillou B, Travagli J-P, Parmetier C (1985) Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55: 794–804PubMedCrossRefGoogle Scholar
  5. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J (1985) Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55: 805–828PubMedCrossRefGoogle Scholar
  6. Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM (1988). Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 104: 954–962PubMedGoogle Scholar
  7. Kim JH, Leeper RD (1983) Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy: a new approach. Cancer 52: 954–957PubMedCrossRefGoogle Scholar
  8. Mazzaferri EL, Rice RR (1992) Management of intrathyroidal papillary thyroid carcinoma. Advances in Endocrinology Metabolism 3: 139–178Google Scholar
  9. Robbins J, Merino MJ, Boice JD Jr, Rone E, Ain KB, Alexander HR, Norton JA, Reynolds J (1991) Thyroid cancer: a lethal endocrine neoplasm. Annals of Internal Medicine 115: 133–147PubMedCrossRefGoogle Scholar
  10. Sobol H, Narod SA, Nakamura Y et al. (1989) Screening for multiple endocrine neoplasia type 2a with DNA-polymorphian analysis. New England Journal of Medicine 321: 996–1000PubMedCrossRefGoogle Scholar
  11. Wong JB, Kaplan MM, Meyer KB, Pauker SG (1990) Ablative radioactive iodine therapy for apparently localized thyroid carcinoma: a decision analytic perspective. Endocrinology and Metabolism Clinics of North America 19: 741–760PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • C. B. Caldwell
  • C. D. ShermanJr.

There are no affiliations available

Personalised recommendations